USD 1.2
(0.0%)
Year | EBITDA | EBITDA Growth |
---|---|---|
2023 | - ILS | -20733.33% |
2022 | - ILS | 99.81% |
2021 | - ILS | -145.65% |
2020 | -9.98 Million ILS | 79.45% |
2019 | -31.46 Million ILS | -138.83% |
2018 | 99.84 Million ILS | 28.59% |
2017 | 86.65 Million ILS | -62.15% |
2016 | 228.92 Million ILS | 87.95% |
2015 | -43.43 Million ILS | -77.38% |
2014 | 538.56 Million ILS | 12.29% |
2013 | -53.17 Million ILS | -14.24% |
2012 | -10.02 Million ILS | -24.7% |
2011 | 397.46 Million ILS | 16.0% |
2010 | 66.51 Million ILS | 748.9% |
2009 | -22.03 Million ILS | -72.76% |
2008 | 507.38 Million ILS | -78.21% |
2007 | 1.26 Billion ILS | 48.5% |
2006 | 818.74 Million ILS | 117.23% |
2005 | 336.89 Million ILS | 325.58% |
2004 | 349.65 Million ILS | -36.26% |
2003 | 179.69 Million ILS | 611.95% |
2002 | -28.35 Million ILS | -166.63% |
2001 | 75.57 Million ILS | 206.91% |
2000 | 20.42 Million ILS | 45.39% |
1999 | -60.76 Million ILS | -169.57% |
1998 | -27.04 Million ILS | -126.09% |
1997 | -7.77 Million ILS | 10.49% |
1996 | 93.79 Million ILS | 0.0% |
Year | EBITDA | EBITDA Growth |
---|---|---|
2024 Q2 | -3.9 Million ILS | 100.0% |
2024 Q1 | -3.9 Million ILS | 0.0% |
2023 FY | - ILS | -20733.33% |
2023 Q2 | -4.11 Million ILS | 0.0% |
2023 Q1 | -4.11 Million ILS | -247.9% |
2023 Q4 | -260.5 Thousand ILS | 0.0% |
2023 Q3 | -260.5 Thousand ILS | 93.67% |
2022 FY | - ILS | 99.81% |
2022 Q1 | -1.26 Million ILS | 74.88% |
2022 Q4 | 2.78 Million ILS | 0.0% |
2022 Q3 | 2.78 Million ILS | 319.49% |
2022 Q2 | -1.26 Million ILS | 0.0% |
2021 Q4 | -5.04 Million ILS | 0.0% |
2021 Q1 | -1.52 Million ILS | 36.06% |
2021 Q3 | -5.04 Million ILS | -230.81% |
2021 Q2 | -1.52 Million ILS | 0.0% |
2021 FY | - ILS | -145.65% |
2020 Q1 | -2.6 Million ILS | -116.19% |
2020 Q4 | -2.38 Million ILS | 0.0% |
2020 FY | - ILS | 79.45% |
2020 Q3 | -2.38 Million ILS | 8.48% |
2020 Q2 | -2.6 Million ILS | 0.0% |
2019 Q3 | -4.7 Million ILS | -117.71% |
2019 Q1 | 26.58 Million ILS | -67.76% |
2019 Q2 | 26.58 Million ILS | 0.0% |
2019 Q4 | 16.1 Million ILS | 441.96% |
2019 FY | - ILS | -138.83% |
2018 Q2 | -287.5 Thousand ILS | 0.0% |
2018 Q1 | -287.5 Thousand ILS | 90.33% |
2018 FY | - ILS | 28.59% |
2018 Q4 | 82.46 Million ILS | 98269.05% |
2018 Q3 | -84 Thousand ILS | 70.78% |
2017 FY | - ILS | -62.15% |
2017 Q4 | -2.97 Million ILS | 0.0% |
2017 Q1 | 10.91 Million ILS | -78.3% |
2017 Q2 | 10.91 Million ILS | 0.0% |
2017 Q3 | -2.97 Million ILS | -127.24% |
2016 Q3 | -24.66 Million ILS | -356.31% |
2016 Q4 | 50.28 Million ILS | 303.91% |
2016 FY | - ILS | 87.95% |
2016 Q1 | -11.87 Million ILS | -114.07% |
2016 Q2 | 9.62 Million ILS | 181.01% |
2015 FY | - ILS | -77.38% |
2015 Q3 | -68 Thousand ILS | 99.84% |
2015 Q2 | -41.88 Million ILS | -148.78% |
2015 Q4 | 84.39 Million ILS | 124204.41% |
2015 Q1 | -16.83 Million ILS | 96.91% |
2014 Q4 | -544.36 Million ILS | -951.77% |
2014 FY | - ILS | 12.29% |
2014 Q2 | 392.89 Million ILS | 124.12% |
2014 Q3 | -51.75 Million ILS | -113.17% |
2014 Q1 | -1.62 Billion ILS | -88.85% |
2013 Q3 | 216.99 Million ILS | -33.74% |
2013 FY | - ILS | -14.24% |
2013 Q4 | -862.44 Million ILS | -497.45% |
2013 Q1 | -685 Thousand ILS | 96.38% |
2013 Q2 | 327.48 Million ILS | 47908.32% |
2012 Q3 | 18.1 Million ILS | 134.59% |
2012 Q4 | -18.93 Million ILS | -204.54% |
2012 Q2 | -52.34 Million ILS | -123.76% |
2012 FY | - ILS | -24.7% |
2012 Q1 | 220.29 Million ILS | 7.55% |
2011 Q1 | 20.42 Million ILS | -89.41% |
2011 Q2 | 32.25 Million ILS | 57.91% |
2011 Q3 | 135.65 Million ILS | 320.58% |
2011 Q4 | 204.83 Million ILS | 51.0% |
2011 FY | - ILS | 16.0% |
2010 Q4 | 192.94 Million ILS | 2167.3% |
2010 FY | - ILS | 748.9% |
2010 Q1 | -53.5 Million ILS | 75.59% |
2010 Q2 | 374.78 Million ILS | 800.52% |
2010 Q3 | 8.51 Million ILS | -97.73% |
2009 Q3 | -98.02 Million ILS | 32.76% |
2009 FY | - ILS | -72.76% |
2009 Q1 | 1.66 Million ILS | -99.46% |
2009 Q2 | -145.78 Million ILS | -8881.99% |
2009 Q4 | -219.14 Million ILS | -123.56% |
2008 Q1 | 8.42 Million ILS | -99.16% |
2008 Q2 | 52.4 Million ILS | 522.26% |
2008 Q3 | -79.91 Million ILS | -252.5% |
2008 FY | - ILS | -78.21% |
2008 Q4 | 309.98 Million ILS | 487.89% |
2007 Q4 | 1 Billion ILS | 8891.21% |
2007 FY | - ILS | 48.5% |
2007 Q3 | 11.2 Million ILS | 165.67% |
2007 Q2 | -17.06 Million ILS | -959.76% |
2007 Q1 | 1.98 Million ILS | -99.76% |
2006 Q1 | -23.45 Million ILS | -123.99% |
2006 FY | - ILS | 117.23% |
2006 Q3 | 5.27 Million ILS | 111.85% |
2006 Q4 | 818.89 Million ILS | 15413.55% |
2006 Q2 | -44.52 Million ILS | -89.82% |
2005 FY | - ILS | 325.58% |
2005 Q2 | 15.69 Million ILS | 134.18% |
2005 Q1 | -45.92 Million ILS | -2291.67% |
2005 Q4 | 97.77 Million ILS | -29.16% |
2005 Q3 | 138.02 Million ILS | 779.34% |
2004 Q1 | 156.52 Million ILS | 2026.4% |
2004 Q2 | 19.38 Million ILS | -87.62% |
2004 Q3 | -141.22 Million ILS | -828.68% |
2004 Q4 | -1.92 Million ILS | 98.64% |
2004 FY | - ILS | -36.26% |
2003 FY | - ILS | 611.95% |
2003 Q3 | -7.75 Million ILS | 71.8% |
2003 Q1 | -2.22 Million ILS | 73.98% |
2003 Q2 | -6.03 Million ILS | -1135.77% |
2003 Q4 | 7.36 Million ILS | 194.98% |
2002 Q4 | -8.54 Million ILS | -466.76% |
2002 Q1 | -4.3 Million ILS | -113.91% |
2002 Q2 | 7.36 Million ILS | 271.12% |
2002 FY | - ILS | -166.63% |
2002 Q3 | 33.91 Thousand ILS | -68.35% |
2001 Q2 | 148.11 Million ILS | 6671.08% |
2001 FY | - ILS | 206.91% |
2001 Q4 | 30.93 Million ILS | 152.91% |
2001 Q3 | -58.46 Million ILS | -139.47% |
2001 Q1 | -2.25 Million ILS | 86.37% |
2000 Q2 | -4.6 Million ILS | 69.78% |
2000 Q1 | -8.14 Million ILS | 95.89% |
2000 Q3 | -18.82 Million ILS | -113.63% |
2000 FY | - ILS | 45.39% |
2000 Q4 | -16.53 Million ILS | -79.33% |
1999 Q3 | 86.3 Million ILS | 4.75% |
1999 Q2 | 82.38 Million ILS | 0.94% |
1999 Q1 | 81.62 Million ILS | 802.56% |
1999 Q4 | -347.58 Million ILS | -502.76% |
1999 FY | - ILS | -169.57% |
1998 Q2 | 367.05 Thousand ILS | 1.89% |
1998 FY | - ILS | -126.09% |
1998 Q1 | 360.25 Thousand ILS | 100.03% |
1998 Q4 | -11.61 Million ILS | -3121.17% |
1998 Q3 | 384.55 Thousand ILS | 4.77% |
1997 FY | - ILS | 10.49% |
1997 Q1 | 374.12 Million ILS | 132.69% |
1997 Q4 | -1.19 Billion ILS | -393.37% |
1997 Q2 | 447.75 Million ILS | 19.68% |
1997 Q3 | 407.1 Million ILS | -9.08% |
1996 Q2 | 389.57 Million ILS | 3.18% |
1996 FY | - ILS | 0.0% |
1996 Q3 | 411.81 Million ILS | 5.71% |
1996 Q1 | 377.58 Million ILS | 0.0% |
1996 Q4 | -1.14 Billion ILS | -377.92% |
Name | EBITDA | EBITDA Difference |
---|---|---|
AVITA Medical, Inc. | -39.56 Million USD | 100.0% |
Manhattan Scientifics, Inc. | -1.16 Million USD | 100.0% |
Össur hf. | 137.38 Million USD | 100.0% |
QHSLab, Inc. | -91.29 Thousand USD | 100.0% |
Wellstar International, Inc. | -1.35 Million USD | 100.0% |
Össur hf. | 137.38 Million USD | 100.0% |
CVR Medical Corp. | - USD | NaN% |
Bionovate Technologies Corp | - USD | NaN% |
Escalon Medical Corp. | -58.46 Thousand USD | 100.0% |
Aurora Spine Corporation | -454.37 Thousand USD | 100.0% |
BrainsWay Ltd. | -2.31 Million USD | 100.0% |
Lattice Biologics Ltd. | - USD | NaN% |
BioElectronics Corporation | -274.29 Thousand USD | 100.0% |
Hamilton Thorne Ltd. | 5.52 Million USD | 100.0% |
Vivos Inc. | -2.79 Million USD | 100.0% |
Kelyniam Global, Inc. | -197.69 Thousand USD | 100.0% |
REMSleep Holdings, Inc. | -1.66 Million USD | 100.0% |
Zecotek Photonics Inc. | -3.44 Million USD | 100.0% |
Avitar, Inc. | -1.66 Million USD | 100.0% |
Nanomix Corporation | -8.13 Million USD | 100.0% |
EKF Diagnostics Holdings plc | 9.77 Million USD | 100.0% |
Theraclion SA | -2.05 Million USD | 100.0% |
Lifeline Biotechnologies, Inc. | - USD | NaN% |
Positron Corporation | -1.45 Million USD | 100.0% |
Rafina Innovations Inc. | - USD | NaN% |
Electromedical Technologies, Inc. | -1.72 Million USD | 100.0% |
Lombard Medical, Inc. | -28.06 Million USD | 100.0% |
ALR Technologies Inc. | -6.4 Million USD | 100.0% |
Stratec SE | 39.91 Million USD | 100.0% |
Vycor Medical, Inc. | 100.94 Thousand USD | 100.0% |
Heart Tronics, Inc. | -14.85 Million USD | 100.0% |
MicroPort Scientific Corporation | -347.57 Million USD | 100.0% |
VMS Rehab Systems, Inc. | -68.55 USD | 100.0% |
NewCardio, Inc. | -9.37 Million USD | 100.0% |
Guided Therapeutics, Inc. | -3.12 Million USD | 100.0% |
Ingen Technologies, Inc. | -8639.00 USD | 100.0% |
Odyssey Group International, Inc. | -2.13 Million USD | 100.0% |
CYduct Diagnostics, Inc. | -378.9 Thousand USD | 100.0% |
Wellness Center USA, Inc. | -707.03 Thousand USD | 100.0% |
SANUWAVE Health, Inc. | -9.15 Million USD | 100.0% |
IR-Med Inc. | -4.89 Million USD | 100.0% |
Perimeter Medical Imaging AI, Inc. | -13.27 Million USD | 100.0% |
Polarean Imaging plc | -11.19 Million USD | 100.0% |
United American Healthcare Corporation | -59 Thousand USD | 100.0% |
ECGI Holdings, Inc. | -2.99 Million USD | 100.0% |
Nu-Med Plus, Inc. | -118.25 Thousand USD | 100.0% |
Capital Group Holdings, Inc. | -629.18 Thousand USD | 100.0% |
ADM Tronics Unlimited, Inc. | -514.02 Thousand USD | 100.0% |
Medical Supply International USA, Inc. | 456.06 Thousand USD | 100.0% |
Urologix, Inc. | -6.34 Million USD | 100.0% |
Rapid Therapeutic Science Laboratories, Inc. | -1.23 Million USD | 100.0% |
Nexeon MedSystems Inc. | -765.96 Thousand USD | 100.0% |
SS Innovations International, Inc. | -20.37 Million USD | 100.0% |
Qualis Innovations, Inc. | -222.81 Thousand USD | 100.0% |
Smith & Nephew plc | 1 Billion USD | 100.0% |
NIOX Group Plc | 11.07 Million USD | 100.0% |
Fuse Medical, Inc. | 1.83 Million USD | 100.0% |
Broncus Holding Corporation | -25.19 Million USD | 100.0% |
Brain Scientific Inc. | -7.93 Million USD | 100.0% |
Pressure BioSciences, Inc. | -9.39 Million USD | 100.0% |
Health Logic Interactive Inc. | -18.4 Thousand USD | 100.0% |